Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €18.0M | €11.3M | €4.1M | €3.9M | €1.3M | €2.7M |
| Research & development | — | — | — | — | −€136,000 | — |
| Operating expenses | €1.2M | €15.3M | €13.1M | €8.4M | — | — |
| Operating income | −€2.4M | −€15.6M | −€11.2M | −€4.2M | −€4.0M | €558,200 |
| Operating margin | −13.10% | −138.74% | −269.24% | −108.44% | −316.73% | 21.05% |
| EBITDA | €6.7M | −€14.9M | −€7.5M | −€4.6M | — | — |
| EBITDA margin | 37.34% | −132.33% | −180.27% | −117.86% | — | — |
| Net income | −€5.7M | −€10.9M | −€7.8M | −€3.4M | −€3.5M | €418,300 |
| Net profit margin | −31.94% | −96.40% | −189.12% | −86.50% | −279.14% | 15.77% |
| Basic EPSper basic share | -€0.39 | -€0.75 | -€0.55 | -€0.24 | -€0.26 | €0.21 |
| Diluted EPSper diluted share | -€0.39 | -€0.75 | -€0.55 | -€0.24 | -€0.26 | €0.21 |